1h Free Analyst Time
The point of care glucose testing market is forecasted to grow by USD 874.6 million during 2023-2028, accelerating at a CAGR of 4.91% during the forecast period. The report on the point of care glucose testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increase in the number of diabetes cases and rising awareness about diabetes, growing geriatric population, and increasing unmet medical needs for the diagnosis and management of diabetes.
The point of care glucose testing market is segmented as below:
By Type
- Strips
- Lancets and lancing devices
- Meters
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the point of care glucose testing market covers the following areas:
- Point of care glucose testing market sizing
- Point of care glucose testing market forecast
- Point of care glucose testing market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Type
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Opportunity/Restraints
10 Competitive Landscape
11 Competitive Analysis
12 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global point of care glucose testing market: Abbott Laboratories, ACON Laboratories Inc., Bayer AG, Becton Dickinson and Co., Danaher Corp., EKF Diagnostics Holdings Plc, F. Hoffmann La Roche Ltd., Johnson and Johnson Services Inc., LifeScan IP Holdings LLC, Nipro Corp., Nova Biomedical Corp., PHC Holdings Corp., Prodigy Diabetes Care LL, PTS Diagnostics, Sekisui Medical Co. Ltd., Siemens Healthineers AG, Trinity Biotech Plc, and Trivida Health Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is focus on introducing low-cost test strips."
According to the report, one of the major drivers for this market is the increase in the number of diabetes cases and rising awareness about diabetes.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- ACON Laboratories Inc.
- Bayer AG
- Becton Dickinson and Co.
- Danaher Corp.
- EKF Diagnostics Holdings Plc
- F. Hoffmann La Roche Ltd.
- Johnson and Johnson Services Inc.
- LifeScan IP Holdings LLC
- Nipro Corp.
- Nova Biomedical Corp.
- PHC Holdings Corp.
- Prodigy Diabetes Care LL
- PTS Diagnostics
- Sekisui Medical Co. Ltd.
- Siemens Healthineers AG
- Trinity Biotech Plc
- Trivida Health Inc.
